Fahim Abbasi
Overview
Explore the profile of Fahim Abbasi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
2994
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kho P, Stell L, Jimenez S, Zanetti D, Panyard D, Watson K, et al.
Front Endocrinol (Lausanne)
. 2025 Feb;
15:1492778.
PMID: 39902167
Objective: South Asians (SAs) may possess a unique predisposition to insulin resistance (IR). We explored this possibility by investigating the relationship between 'gold standard' measures of adiposity, fitness, selected proteomic...
2.
Metwally A, Perelman D, Park H, Wu Y, Jha A, Sharp S, et al.
Nat Biomed Eng
. 2024 Dec;
PMID: 39715896
The classification of type 2 diabetes and prediabetes does not consider heterogeneity in the pathophysiology of glucose dysregulation. Here we show that prediabetes is characterized by metabolic heterogeneity, and that...
3.
Haas S, Abbasi F, Watson K, Robakis T, Myoraku A, Frangou S, et al.
Biol Psychiatry Cogn Neurosci Neuroimaging
. 2024 Nov;
10(3):278-285.
PMID: 39615789
Background: As people live longer, maintaining brain health becomes essential for extending health span and preserving independence. Brain degeneration and cognitive decline are major contributors to disability. In this study,...
4.
Kho P, Wary N, Zanetti D, Abbasi F, Knowles J, Panyard D, et al.
medRxiv
. 2024 Nov;
PMID: 39606342
Background: We previously reported significant correlations between a direct measure of insulin sensitivity (IS) and blood levels of proteins measured using the Proximity Extension Assay (PEA) in two European cohorts....
5.
Chen M, Kho P, Guarischi-Sousa R, Zhou J, Panyard D, Azizi Z, et al.
Front Cardiovasc Med
. 2024 Oct;
11:1478600.
PMID: 39416432
Background And Aims: Ultrasound derived carotid intima-media thickness (cIMT) is valuable for cardiovascular risk stratification. We assessed the relative importance of traditional atherosclerosis risk factors and plasma proteins in predicting...
6.
Gupte T, Azizi Z, Kho P, Zhou J, Chen M, Panyard D, et al.
medRxiv
. 2024 Sep;
PMID: 39314942
Background: While risk stratification for atherosclerotic cardiovascular disease (ASCVD) is essential for primary prevention, current clinical risk algorithms demonstrate variability and leave room for further improvement. The plasma proteome holds...
7.
Plasma proteomic signatures for type 2 diabetes mellitus and related traits in the UK Biobank cohort
Gupte T, Azizi Z, Kho P, Zhou J, Nzenkue K, Chen M, et al.
medRxiv
. 2024 Sep;
PMID: 39314935
Aims/hypothesis: The plasma proteome holds promise as a diagnostic and prognostic tool that can accurately reflect complex human traits and disease processes. We assessed the ability of plasma proteins to...
8.
Kho P, Stell L, Jimenez S, Zanetti D, Panyard D, Watson K, et al.
medRxiv
. 2024 Sep;
PMID: 39281745
Objective: South Asians (SAs) may possess a unique predisposition to insulin resistance (IR). We explored this possibility by investigating the relationship between 'gold standard' measures of adiposity, fitness, selected proteomic...
9.
Metwally A, Perelman D, Park H, Wu Y, Jha A, Sharp S, et al.
medRxiv
. 2024 Aug;
PMID: 39108516
Type 2 diabetes (T2D) and prediabetes are classically defined by the level of fasting glucose or surrogates such as hemoglobin HbA1c. This classification does not take into account the heterogeneity...
10.
Zhang P, Munier J, Wiese C, Vergnes L, Link J, Abbasi F, et al.
Nat Commun
. 2024 Jul;
15(1):5571.
PMID: 38956041
Statin drugs lower blood cholesterol levels for cardiovascular disease prevention. Women are more likely than men to experience adverse statin effects, particularly new-onset diabetes (NOD) and muscle weakness. Here we...